Free Trial

NeuroBo Pharmaceuticals (NRBO) SEC Filings & 10K Form

NeuroBo Pharmaceuticals logo
$1.54 -0.04 (-2.22%)
As of 03/31/2025

Recent NeuroBo Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/27/2025
4:05 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form POS AM
03/27/2025
4:07 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
4:15 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
6:31 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:30 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:30 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
4:31 PM
Kim Hyung Heon (Reporting)
MetaVia Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
MetaVia Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:10 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:35 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals (Subject)
NeuroBo Pharmaceuticals, Inc. (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:41 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form DEF 14A
04/30/2024
7:42 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form ARS
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
04/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form EFFECT
04/17/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners